동남권원자력의학원은 방사선의 의학적 이용에 대한 연구, 동남권 지역주민의 의료서비스 향상과 방사선비상진료 업무 수행을 위해 2010년 7월 16일 개원한 대한민국 미래창조과학부 산하 기타공공기관인 한국원자력의학원 분원이다. 부산광역시 기장군 장안읍좌동길 40에 위치하고 있다.

During the past decade, Dongnam Institute of Radiological & Medical Sciences conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dongnam Institute of Radiological & Medical Sciences" #1 sponsor was "National Cancer Center, Korea" with 5 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Korea Cancer Center Hospital" with 4 trials sponsored, "Celgene" with 1 trials sponsored and "Hallym University Medical Center" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dongnam Institute of Radiological & Medical Sciences" #1 collaborator was "Dongnam Institute of Radiological & Medical Sciences" with 3 trials as a collaborator, "Incheon St.Mary's Hospital" with 3 trials as a collaborator, "Inha University Hospital" with 3 trials as a collaborator, "Inje University" with 2 trials as a collaborator and "Seoul National University Hospital" with 2 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Dongnam Institute of Radiological & Medical Sciences" are "Hepatocellular Carcinoma" (4 trials), "Early Gastric Cancer" (3 trials), "Gastric Cancer" (3 trials), "Breast Cancer" (1 trials) and "Carcinoma, Non-Small Cell Lung" (1 trials). Many other conditions were trialed in "Dongnam Institute of Radiological & Medical Sciences" in a lesser frequency.

Most popular intervention types in "Dongnam Institute of Radiological & Medical Sciences" are "Drug" (6 trials), "Procedure" (4 trials), "Radiation" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Stereotactic ablative radiotherapy" (2 trials), "Alectinib" (1 trials), "Atezolizumab" (1 trials), "Cisplatin" (1 trials) and "Computed tomography, Chest X-ray, and blood test" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dongnam Institute of Radiological & Medical Sciences" are 16 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Dongnam Institute of Radiological & Medical Sciences". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Dongnam Institute of Radiological & Medical Sciences, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dongnam Institute of Radiological & Medical Sciences, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".